STAGE IVB LIP AND ORAL CAVITY CANCER AJCC V8
Clinical trials for STAGE IVB LIP AND ORAL CAVITY CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVB LIP AND ORAL CAVITY CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVB LIP AND ORAL CAVITY CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for patients who Can't take standard chemo
Disease control OngoingThis early-stage trial is testing a new drug called peposertib combined with radiation therapy for patients with advanced head and neck cancer who cannot take the standard chemotherapy drug cisplatin. The main goals are to find the safest and most effective dose of peposertib and…
Matched conditions: STAGE IVB LIP AND ORAL CAVITY CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug combo aims to tame tough head and neck cancers
Disease control OngoingThis study is testing whether combining an immunotherapy drug (cemiplimab) with two low-dose chemotherapy drugs works better for treating head and neck cancer that has returned or spread. It will involve about 46 patients whose cancer has come back or spread and who haven't had o…
Matched conditions: STAGE IVB LIP AND ORAL CAVITY CANCER AJCC V8
Phase: PHASE2 • Sponsor: Marcelo Bonomi • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC